Michael F. Leahy

Improved outcomes and reduced costs associated with a health‐system–wide patient blood management program: a retrospective observational study in four major adult tertiary‐care hospitals

Michael F. Leahy, Axel Hofmann, Simon Towler et al. · Transfusion · 2017 · 436 citations · Full text

Medicine, Health Systems, Hematology +17

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 185 citations

Medicine, Hematology, Pharmacology +9

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

Timothy P. Hughes, Susan Branford, Deborah L. White et al. · Blood · 2008 · 177 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +10

A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk

María J. Redondo, Susan Geyer, Andrea K. Steck et al. · Diabetes Care · 2018 · 169 citations · Full text

Life Sciences, Endocrinology, Genetics +17

Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

Jeffrey I. Weitz, Sylvia Haas, Walter Ageno et al. · Journal of Thrombosis and Thrombolysis · 2020 · 115 citations · Full text

Medicine, Oncology, Cancer Epidemiology +11